Novartis Shows Growing Strength in Lung Cancer Innovation

June 3, 2019

Primary analysis of investigational capmatinib (INC280) in the GEOMETRY mono-1 study demonstrates promising efficacy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring MET exon-14 skipping mutation. Overall response rate among patients receiving capmatinib was 68% for treatment-naive and 41% for previously treated patients; median duration of response was also clinically meaningful irrespective of prior line of therapy.

Spotlight

InVivoLink

InVivoLink is a rapidly emerging health care technology company based in Nashville, Tn. Our care management platform optimizes care delivery for orthopedic and spine procedures. InVivoLink promotes collaboration between hospitals and physicians by providing episodic data on cost, quality, and performance. InVivoLink’s comprehensive implant registry tracks outcomes and cost data to reduce physician-preference item spend. With enterprise analytics and a patient engagement portal that empowers recovery, InVivoLink has pioneered an evidence-based technology that advances clinical excellence.

OTHER WHITEPAPERS
news image

Innovative Medical Education in the Digital Era

whitePaper | November 24, 2022

Universities have traditionally aimed to instill in their students the ability to interpret information as well as the joy of learning. However, today’s universities are challenged with the need to also incorporate technological advances without forsaking the solid principles at their foundation.

Read More
news image

Three Challenges Facing Study Start Up and the Low-Code Automation Solution

whitePaper | November 24, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies

Read More
news image

Future of medical science

whitePaper | May 14, 2022

Medical science is currently being transformed by scientific discoveries that will dramatically advance the way we diagnose and treat different diseases.

Read More
news image

2023 State of Cybersecurityfor Medical Devices andHealthcare Systems

whitePaper | August 7, 2023

Improving patient safety and protecting healthcare from cybersecurity threats is our top priority at Health-ISAC. The healthcare sector is essential to a country’s national security infrastructure. Cyber-attacks on healthcare systems can have broader implications for public health and national security.

Read More
news image

INDICATION-SPECIFIC PRICING OF PHARMACEUTICALS IN THE UNITED STATES HEALTH CARE SYSTEM

whitePaper | November 24, 2022

The 2015 ICER Policy Summit convened an influential group of evidence policy leaders from insurers, pharmacy benefit management firms.

Read More
news image

Improving Health Outcomes With Data and AI

whitePaper | July 26, 2022

More than most industries, healthcare and life sciences has been constantly revolutionized by technology. Rapid advances in diagnostics, patient care and drug development have led to remarkable progress in improving patient outcomes and treating diseases.

Read More

Spotlight

InVivoLink

InVivoLink is a rapidly emerging health care technology company based in Nashville, Tn. Our care management platform optimizes care delivery for orthopedic and spine procedures. InVivoLink promotes collaboration between hospitals and physicians by providing episodic data on cost, quality, and performance. InVivoLink’s comprehensive implant registry tracks outcomes and cost data to reduce physician-preference item spend. With enterprise analytics and a patient engagement portal that empowers recovery, InVivoLink has pioneered an evidence-based technology that advances clinical excellence.

Events